newsfilter
← Latest News
GlobeNewswire·

Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4

MALVERN, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, will host a